# Risk Evaluation and Education for Alzheimer's Disease (REVEAL) IV

> **NCT01434667** · NA · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 146 (actual)

## Conditions studied

- Mild Cognitive Impairment

## Interventions

- **BEHAVIORAL:** APOE genotype and Alzheimer's disease risk disclosure
- **BEHAVIORAL:** Alzheimer's disease risk disclosure

## Key facts

- **NCT ID:** NCT01434667
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2018-10-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01434667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01434667, "Risk Evaluation and Education for Alzheimer's Disease (REVEAL) IV". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01434667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*